Guidelines for reporting systematic reviews and meta-analysis

Reporting guidance provided for: Name of guideline website (where available) References including PMID

Systematic reviews and meta-analyses


PRISMA

Using PRISMA (talk)

Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement.
PLoS Med 2009; 6(7): e1000097.
PMID: 19621072
BMJ 2009; 339:b2535. PMID: 19622551
Ann Intern Med 2009; 151(4):264-9, W64.
PMID: 19622511
J Clin Epidemiol 2009; 62(10):1006-12.
PMID: 19631508
Open Med 2009; 3(3);123-130

Liberati A,  Altman DG,  Tetzlaff J,  Mulrow C,  Gøtzsche PC,  et al. The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration.
PLoS Med 2009; 6(7): e1000100.
PMID: 19621070
BMJ 2009; 339:b2700. PMID: 19622552
Ann Intern Med 2009; 151(4):W65-94.
PMID: 19622512

PRISMA Statement replaces the QUOROM guideline (PMID: 10584742 )

Systematic review and meta-analysis abstracts
PRISMA-Abstracts
Beller EM, Glasziou PP, Altman DG, Hopewell S, Bastian H, Chalmers I, Gøtzsche PC, Lasserson T, Tovey D; PRISMA for Abstracts Group. PRISMA for Abstracts: Reporting Systematic Reviews in Journal and Conference Abstracts. PLoS Med. 2013 Apr;10(4):e1001419. PMID: 23585737
Systematic reviews with a focus on health equity
PRISMA-Equity

Welch V, Petticrew M, Tugwell P, Moher D, O'Neill J, et al. (2012) PRISMA-Equity 2012 Extension: Reporting Guidelines for Systematic Reviews with a Focus on Health Equity. PLoS Med 9(10): e1001333. doi:10.1371/journal.pmed.1001333. Link to full-text

Meta-analysis of individual participant data

Riley RD, Lambert PC, bo-Zaid G. Meta-analysis of individual participant data: rationale, conduct, and reporting. BMJ 2010;340:c221. PMID: 20139215
Meta-analyses of observational studies MOOSE Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000; 283(15):2008-2012.
PMID: 10789670

RAMESES: realist syntheses
Wong G, Greenhalgh T, Westhorp G, Buckingham J, Pawson R. RAMESES publication standards: realist syntheses. BMC Med. 2013;11:21.
PMID: 23360677

RAMESES: meta-narrative reviews
Wong G, Greenhalgh T, Westhorp G, Buckingham J, Pawson R. RAMESES publication standards: meta-narrative reviews. BMC Med. 2013;11:20. PMID: 23360661

Other resources that include guidance on reporting

  1. Cochrane Handbook for Systematic Reviews of Interventions, Cochrane Collaboration. Standards for the Reporting of Cochrane Intervention Reviews (MECIR), Cochrane Collaboration.
  2. Little J, Higgins JPT (editors).  The HuGENETM HuGE Review Handbook, version 1.0.  Guidelines for systematic review and meta-analysis of gene disease association studies (see also Systematic Reviews of Genetic Association Studies, PLoS Medicine 2009, 6 (3):e1000028)
  3. Systematic Reviews. CRD's guidance for undertaking reviews in health care. Centre for Reviews and Dissemination, University of York, 2009
  4. Finding What Works in Health Care: Standards for Systematic Reviews. Chapter 5 - Standards for Reporting Systematic Reviews. Institute of Medicine consensus report. 2011 (full text).



Page last edited: 17 May 2013